AzurRx BioPharma, Inc.·4

Jul 20, 9:53 PM ET

Pennington James 4

4 · AzurRx BioPharma, Inc. · Filed Jul 20, 2020

Insider Transaction Report

Form 4
Period: 2019-06-13
Pennington James
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock option (right to buy)

    2019-06-13+110,000110,000 total
    Exercise: $1.75Exp: 2024-06-12Common stock, par value $0.0001 per share (110,000 underlying)
Footnotes (1)
  • [F1]The stock option vests, if at all, upon the achievement of certain specified performance targets. Vesting is conditioned on Mr. Pennington's continued employment by AzurRx BioPharma, Inc. on the applicable vesting date.

Documents

1 file
  • 4
    form4-07202020_060734.xmlPrimary